Labcorp plasma focus™ liquid biopsy test now available

Liquid biopsy test for cancer patients enables oncologists to identify targeted therapies and improve care burlington, n.c. , may 31, 2023 /prnewswire/ -- labcorp (nyse: lh), a leading global life sciences company, has launched labcorp plasma focus, a new liquid biopsy test enabling targeted therapy selection for patients with advanced or metastatic solid tumors.
LH Ratings Summary
LH Quant Ranking